{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:02:32Z","timestamp":1761487352997,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.breast.2005.01.005","type":"journal-article","created":{"date-parts":[[2005,3,18]],"date-time":"2005-03-18T09:42:44Z","timestamp":1111138964000},"page":"264-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["BRCA1 and BRCA2 germ-line mutations and oral contraceptives: to use or not to use"],"prefix":"10.1016","volume":"14","author":[{"given":"Tal","family":"Grenader","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamar","family":"Peretz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meyer","family":"Lifchitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Shavit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.breast.2005.01.005_bib1","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/jnci\/93.11.824","article-title":"Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends","volume":"93","author":"Howe","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.breast.2005.01.005_bib2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1006\/gyno.2002.6853","article-title":"Frequency of BRCA mutations in primary peritoneal carcinoma in Israeli Jewish women","volume":"88","author":"Menczer","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.breast.2005.01.005_bib3","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/00005792-199805000-00006","article-title":"Breast cancer susceptibility genes. BRCA1 and BRCA2","volume":"77","author":"Brody","year":"1998","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.breast.2005.01.005_bib4","first-page":"1457","article-title":"Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence","volume":"57","author":"Ford","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.breast.2005.01.005_bib5","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1073\/pnas.85.9.3044","article-title":"Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families","volume":"85","author":"Newman","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.breast.2005.01.005_bib6","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","article-title":"The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews","volume":"336","author":"Struewing","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2005.01.005_bib7","first-page":"99","article-title":"Screening for genetic risk of breast cancer","volume":"59","author":"Rosenthal","year":"1999","journal-title":"Am Fam Physician"},{"issue":"3","key":"10.1016\/j.breast.2005.01.005_bib8","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium","volume":"62","author":"Ford","year":"1998","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.breast.2005.01.005_bib9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1054\/bjoc.2000.1598","article-title":"The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients","volume":"84","author":"Chen-Shtoyerman","year":"2001","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.breast.2005.01.005_bib10","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1054\/bjoc.2000.1249","article-title":"The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel","volume":"83","author":"Vazina","year":"2000","journal-title":"Br J Cancer"},{"issue":"23","key":"10.1016\/j.breast.2005.01.005_bib11","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/jnci\/94.23.1773","article-title":"Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"94","author":"Narod","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.breast.2005.01.005_bib12","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0959-8049(97)89007-7","article-title":"Tumor biological features of BRCA1-induced breast and ovarian cancer","volume":"33","author":"Johannsson","year":"1997","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.breast.2005.01.005_bib13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/(SICI)1097-0142(19970801)80:3<435::AID-CNCR11>3.0.CO;2-Y","article-title":"Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women","volume":"80","author":"Karp","year":"1997","journal-title":"Cancer"},{"issue":"17","key":"10.1016\/j.breast.2005.01.005_bib14","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/jnci\/91.17.1475","article-title":"Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers","volume":"91","author":"Rebbeck","year":"1999","journal-title":"J Natl Cancer Inst"},{"issue":"9245","key":"10.1016\/j.breast.2005.01.005_bib15","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(00)03258-X","article-title":"Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group","volume":"356","author":"Narod","year":"2000","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.breast.2005.01.005_bib16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0301-2115(98)00286-3","article-title":"Genetic testing of breast and ovarian cancer patients: clinical characteristics and hormonal risk modifiers","volume":"85","author":"Kaduri","year":"1999","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.breast.2005.01.005_bib17","doi-asserted-by":"crossref","unstructured":"Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53297 women with breast cancer and 100239 women without breast cancer from 54 epidemiological studies. Collaborative Group on Hormonal Factors in Breast Cancer Lancet 1996;347:1713\u201327.","DOI":"10.1016\/S0140-6736(96)90806-5"},{"issue":"10","key":"10.1016\/j.breast.2005.01.005_bib18","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/oxfordjournals.aje.a116429","article-title":"Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group","volume":"136","author":"Whittemore","year":"1992","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.breast.2005.01.005_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ijc.2910490112","article-title":"Pooled analysis of 3 European case-control studies of epithelial ovarian cancer: III. Oral contraceptive use","volume":"49","author":"Franceschi","year":"1991","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.breast.2005.01.005_bib20","first-page":"271","article-title":"Effect of progestin on the ovarian epithelium of macaques: cancer prevention through apoptosis?","volume":"5","author":"Rodriguez","year":"1998","journal-title":"J Soc Gynecol Investig"},{"issue":"7","key":"10.1016\/j.breast.2005.01.005_bib21","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM199808133390702","article-title":"Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group","volume":"339","author":"Narod","year":"1998","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.breast.2005.01.005_bib22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJM200107263450401","article-title":"Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation","volume":"345","author":"Modan","year":"2001","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.breast.2005.01.005_bib23","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJM200112063452312","article-title":"Ovarian cancer, oral contraceptives, and BRCA mutations","volume":"345","author":"Narod","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2005.01.005_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199901143400201","article-title":"Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer","volume":"340","author":"Hartmann","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2005.01.005_bib25","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2005.01.005_bib26","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/jama.1997.03540360065034","article-title":"Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium","volume":"277","author":"Burke","year":"1997","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.breast.2005.01.005_bib27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1148\/radiology.215.1.r00ap01267","article-title":"Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results","volume":"215","author":"Kuhl","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.breast.2005.01.005_bib28","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/jnci\/93.14.1095","article-title":"Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer","volume":"93","author":"Stoutjesdijk","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"5645","key":"10.1016\/j.breast.2005.01.005_bib29","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","article-title":"Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2","volume":"302","author":"King","year":"2003","journal-title":"Science"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977605000378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977605000378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:21:39Z","timestamp":1760775699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977605000378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0960977605000378"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2005.01.005","relation":{},"ISSN":["0960-9776"],"issn-type":[{"type":"print","value":"0960-9776"}],"subject":[],"published":{"date-parts":[[2005,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BRCA1 and BRCA2 germ-line mutations and oral contraceptives: to use or not to use","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2005.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}